Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham S Taylor

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell linesTracey A Haigh, Xiaorong Lin, Hui Jia, et al.
Plos Pathogens|January 5, 2012
Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2Jianmin Zuo, Wendy A Thomas, Tracey A Haigh, et al.
Plos Pathogens|December 19, 2009
T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope displayLaura K Mackay, Heather M Long, Jill M Brooks, et al.
Blood|January 9, 2013
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205Carol S Leung, Michael A Maurer, Sonja Meixlsperger, et al.
Plos Pathogens|April 21, 2016
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic VaccinationJill M Brooks, Heather M Long, Rose J Tierney, et al.
Blood Advances|January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell linesSarah T Diepstraten, Catherine Chang, Lin Tai, et al.
The Journal of Clinical Investigation|May 2, 2019
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomasJulia Rühl, Carmen Citterio, Christine Engelmann, et al.
Plos Pathogens|June 6, 2024
Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosisOlivia G Thomas, Tracey A Haigh, Deborah Croom-Carter, et al.
Plos One|September 21, 2017
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancerAlexander C Dowell, Ellen Cobby, Kaisheng Wen, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2007
CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patientsXiaorong Lin, Nancy H Gudgeon, Edwin P Hui, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell linesTracey A Haigh, Xiaorong Lin, Hui Jia, et al.
Plos Pathogens|January 5, 2012
Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2Jianmin Zuo, Wendy A Thomas, Tracey A Haigh, et al.
Plos Pathogens|December 19, 2009
T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope displayLaura K Mackay, Heather M Long, Jill M Brooks, et al.
Blood|January 9, 2013
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205Carol S Leung, Michael A Maurer, Sonja Meixlsperger, et al.
Plos Pathogens|April 21, 2016
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic VaccinationJill M Brooks, Heather M Long, Rose J Tierney, et al.
Blood Advances|January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell linesSarah T Diepstraten, Catherine Chang, Lin Tai, et al.
The Journal of Clinical Investigation|May 2, 2019
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomasJulia Rühl, Carmen Citterio, Christine Engelmann, et al.
Plos Pathogens|June 6, 2024
Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosisOlivia G Thomas, Tracey A Haigh, Deborah Croom-Carter, et al.
Plos One|September 21, 2017
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancerAlexander C Dowell, Ellen Cobby, Kaisheng Wen, et al.
Cancer Immunology, Immunotherapy : CII|December 21, 2007
CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patientsXiaorong Lin, Nancy H Gudgeon, Edwin P Hui, et al.
Pageof 6